← Leaderboards
Michael Harmata
University Of Missouri-Columbia
$933,737
Attributed
$933,737
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $277.1K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$933,737 · 2
By mechanism
R01$933,737 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Michael Harmata$2,908,042
- Shon R Pulley$166,849
Others in their field
Top investigators on “Cycloalkene”
- Stephen L Buchwald · Massachusetts Institute Of Technology$2,427,654
- K Barry Sharpless · Scripps Research Institute, The$2,077,916
- Joseph M Fox · Massachusetts Institute Of Technology$1,908,589
- Jimmie Dean Weaver · Oklahoma State University Stillwater$1,892,409
- Rick L Danheiser · Massachusetts Institute Of Technology$1,660,283
- W. Dean Harman · University Of Virginia Charlottesville$1,612,646
Research focus
CycloalkeneAnalgesicsAnalogAnti-Inflammatory AgentsAntimicrobialAntitubercular AgentsAreaAspidosperma AlkaloidBaseBiologicalBiological FactorsCarbanionCarbeneChemical AdditionClosureCoupledCyclizationDiterpenesDrug Design /Synthesis /ProductionElisabethin AElisapterosin BErogorgiaeneEstersEthers
Grant awards (4)
Pseudopteroxazole and Related Antitubercular Agents$238,775
R01 · FY2007 · AI · contact PI
Pseudopteroxazole and Related Antitubercular Agents$246,060
R01 · FY2006 · AI · contact PI
Pseudopteroxazole and Related Antitubercular Agents$277,134
R01 · FY2005 · AI
BENZANNULATION APPROACH TO BIARYL ETHERS$171,768
R01 · FY2001 · GM